SARS-CoV-2 Mpro-IN-25

SARS-CoV-2 Mpro-IN-25

• CAS Number: 2205006-23-9
• UNSPSC Description: SARS-CoV-2 Mpro-IN-25 (Compound 3a) is a SARS-CoV-2 protease inhibitor with an IC50 value of 0.26 μM. SARS-CoV-2 Mpro-IN-25 exhibits antiviral activity and can be used in pneumonia-related research[1].
• Target Antigen: Virus Protease
• Type: Reference compound
• Related Pathways: Anti-infection
• Field of Research: Infection; Inflammation/Immunology
• Assay Protocol: https://www.medchemexpress.com/sars-cov-2-mpro-in-25.html
• Smiles: O=C(C1=CC(O)=C(C(O)=C1)O)NC2=CC=C(C=C2)F
• Molecular Weight: 263.22
• References & Citations: [1]de Carvalho MAG, et al. Synthesis, in vitro and in silico evaluation of gallamide and selenogallamide derivatives as inhibitors of the SARS-CoV-2 main protease. Arch Pharm (Weinheim). 2024 Aug 15:e2400253.
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported